Showing results (2321-2330 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|October 7, 2006
Cytotoxic activity of Apomine is due to a novel membrane-mediated cytolytic mechanism independent of apoptosis in the A375 human melanoma cell lineAlan Pourpak, Robert T Dorr, Ross O Meyers, et al.
Investigational New Drugs|April 1, 1992
Menogaril in the treatment of relapsed multiple myeloma. A phase II trial of the Cancer Center of Wake Forest UniversityJ M Cruz, L D Case, H B Dalton, et al.
Investigational New Drugs|August 5, 2004
Antiproliferative effects of ZD0473 (AMD473) in combination with 5-fluorouracil or SN38 in human colorectal cancer cell linesCarmen Plasencia, Albert Abad, Eva Martinez-Balibrea, et al.
Investigational New Drugs|March 4, 2005
Resveratrol regulates cellular PKC alpha and delta to inhibit growth and induce apoptosis in gastric cancer cellsMary Jo Atten, Ernesto Godoy-Romero, Bashar M Attar, et al.
Investigational New Drugs|March 4, 2005
Pomegranate (Punica granatum) pure chemicals show possible synergistic inhibition of human PC-3 prostate cancer cell invasion across MatrigelEphraim Philip Lansky, Gregory Harrison, Paul Froom, et al.
Investigational New Drugs|August 9, 2005
Pre-irradiation 9-amino [20s] camptothecin (9-AC) in patients with newly diagnosed glioblastoma multiformeDaniel Farray, Manmeet S Ahluwalia, Josette Snyder, et al.
Investigational New Drugs|September 26, 2008
A phase II study of S-1 plus irinotecan and oxaliplatin in heavily-treated patients with metastatic colorectal cancerSun Young Kim, Yong Sang Hong, Byung Chang Kim, et al.
Investigational New Drugs|September 23, 2008
Is transketolase like 1 a target for the treatment of differentiated thyroid carcinoma? A study on thyroid cancer cell linesEleonore Fröhlich, Inge Fink, Richard Wahl
Investigational New Drugs|February 12, 2010
Escalating weekly doses of cetuximab and correlation with skin toxicity: a phase I studyCheryl Ho, Randeep Sangha, Laurel Beckett, et al.
Investigational New Drugs|June 16, 2017
A phase Ib study of everolimus combined with metformin for patients with advanced cancerRemco J Molenaar, Tim van de Venne, Mariëtte J Weterman, et al.
Pageof 372